The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This ...

Non-Alcoholic Concentrated Syrup Market Surges to USD 8.2 Billion by 2033, Propelled by 5.0% CAGR - Verified Market Reports (R) ...

As wellness culture is shaping everyday choices, people are more willing to trade indulgence for ingredients that promise ...

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM ...

Leaft Foods has entered a new collaboration with Foodstuffs South Island (FSSI) to test the application of Rubisco ...

The Global 3D Cell Culture Market is poised for strong double-digit growth by 2027, driven by rapid advancements in biotechnology, growing interest in advanced disease models, and a rising need for ...

OQ Technology stated it used Nordic Semiconductor’s nRF9151 SMA development kit to transmit IoT data to its constellation of ...

Discover the Web3 jobs in demand for 2026, the skills companies are hiring for, and how to position yourself in the web3 ...

The platform says 25 million projects were created in its first year as marketers, PMs, nurses, and founders ship real ...

Generative AI and advanced automation have officially crossed the line from support function to core investment capability.

MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM MYQORZO is Company's First FDA-Approv ...